Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
6.63 +0.08 / +1.22%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.63 0.00 / 0.00%
 
Volume: 3.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
AssetsCash4.0M6.0M0.005.5M
 
 
 
 
Short Term Investment Cash-43.0M22.2M-11.3M7.0M
 
 
 
 
 
Cash & Short Term Investments47.9M70.1M58.8M65.9M
 
 
 
 
 
 
ReceivablesReceivables4.1M2.4M6.9M2.9M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets0.000.001.7M1.9M
 
 
 
Current Assets52.0M72.5M67.5M70.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross30.1M26.1M15.7M14.5M
 
 
 
 
 
Depreciation-24.2M-22.1M-12.3M-12.1M
 
 
 
 
 
Intangible Assets0.000.000.0039.1M
 
 
Other Assets1.1M0.00150.0K39.1M
 
 
 
 
Total Assets62.7M80.1M76.3M114.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable658.0K309.0K229.0K793.0K
 
 
 
 
 
Accrued Expenses6.2M2.9M3.0M3.6M
 
 
 
 
 
Other Current Liabilities7.4M3.2M4.0M3.7M
 
 
 
 
 
Other Liabilities9.8M6.7M8.7M6.6M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes0.000.00-2.1M-12.3M
 
 
 
Other Liabilities1.6M1.5M1.1M914.0K
 
 
 
 
 
Total Liabilities11.4M8.3M9.7M35.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity51.3M71.8M66.6M79.0M
 
 
 
 
 
Total Shareholder Equity51.3M71.8M66.6M79.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding33.1M33.8M46.6M60.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account